David McCall

30PUBLICATIONS
102CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRadiation therapyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Jun 03, 2026
Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia.

|Oct 03, 2025
Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia.

Elysia Cohen, Olayinka Okeleji, David McCall

|Sep 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML.

Reeja Raj, Samanta Catueno, Amber Gibson

|Jul 03, 2025
Lymphoid Malignancies in Ataxia-Telangiectasia: Experience with Novel Targeted Therapies.

Samanta Catueno, Ramya Ramakrishnan, Sarah Elitzur

|Jun 09, 2025
Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma.

Kelsey L Corrigan, Amy M Berkman, Jillian Gunther

Pageof 5

Frequent Collaborators

17 joint publications

Miriam Garcia

16 joint publications

Amber Gibson

15 joint publications

Michael Roth

8 joint publications

Courtney DiNardo